Yusuf Dölen (Y Dölen, Yusuf Dolen)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Regulatory T Cells

High Throughput

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science advances

Journal for immunotherapy of cancer

Radboud Universiteit Nijmegen Nijmegen Centre for Molecular Life Sciences

Hacettepe Universitesi Saglik Bilimleri Enstitusu (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Radboud Universiteit Nijmegen Nijmegen Centre for Molecular Life Sciences Sep 15 2013

Netherlands

PostDoc :: Tumor Immunology

Education History

Hacettepe Universitesi Saglik Bilimleri Enstitusu Sep 19 2009 - Sep 05 2013

Turkey

PHD :: Temel Onkoloji

Hacettepe Universitesi Saglik Bilimleri Enstitusu Sep 14 2007 - Sep 10 2009

Turkey

MSC :: Temel Onkoloji

Hacettepe Universitesi Fen Fakultesi Sep 10 1999 - Feb 01 2006

Turkey

BSC :: Biology

Publications

Camille Le Gall, Anna Cammarata, Lukas de Haas, Iván Ramos-Tomillero, Jorge Cuenca-Escalona, Kayleigh Schouren, Zacharias Wijfjes, Anouk M D Becker, Johanna Bödder, Yusuf Dölen, Ingrid Jolanda M De Vries, Carl G Figdor, Georgina Flórez-Grau, Martijn Verdoes
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion. Journal for immunotherapy of cancer 10 (4) (2022)
Johan M S van der Schoot, Felix L Fennemann, Michael Valente, Yusuf Dölen, Iris M Hagemans, Anouk M D Becker, Camille M Le Gall, Duco van Dalen, Alper Cevirgel, Jaco A C van Bruggen, Melanie Engelfriet, Tomislav Čaval, Arthur E H Bentlage, Marieke F Fransen, Maaike Nederend, Jeanette H W Leusen, Albert J R Heck, Gestur Vidarsson, Carl G Figdor, Martijn Verdoes, Ferenc A Scheeren
Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering. Science advances 5 (8) (2019)
M Valente, Yusuf Dölen, E van Dinther, L Vimeux, M Fallet, V Feuillet, C G Figdor
Cross-talk between iNKT cells and CD8 T cells in the spleen requires the IL-4/CCL17 axis for the generation of short-lived effector cells. Proceedings of the National Academy of Sciences of the United States of America 116 (51) (2019)